Allergan, Inc. (NYSE:AGN)

CAPS Rating: 4 out of 5

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.

Recs

0
Player Avatar TerryHoodSr (< 20) Submitted: 9/10/2012 1:55:31 PM : Outperform Start Price: $88.94 AGN Score: +4.23

2013 EPS 4.76 TP $102

Featured Broker Partners


Advertisement